From: A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis
Parameters | Patients with sepsis (n= 24) | Control subjects (n= 12) |
---|---|---|
Age, median years (range) | 62 (29 to 91) | 57 (44 to 59) |
Males, percentage (number) | 54 (13) | 42 (5) |
APACHEII at admission, median (range) | 20 (10 to 33) | n/a |
MOD score at admission, median (range) | 6 (1 to 10) | n/a |
28-day mortality, percentage (number) | 42 (10) | n/a |
Nosocomial infection, percentage (number) | 21 (5) | n/a |
Length of ICU stay, median days (range) | 6.5 (1 to 28) | n/a |
Length of hospitalization, median days (range) | 11.5 (1 to 89) | n/a |
Ventilation days, median days (range) | 4 (1 to 19) | n/a |
WBC at enrollment, median cells/μL × 10-3 (range) | 12.8 (0.4 to 47) | n/a |
Absolute lymphocyte count, median cells/μl × 10-3 (range) | 0.97 (.07 to 4.8) | n/a |
Comorbidities, percentages | Â | none |
End stage renal disease | 17 | Â |
Cirrhosis | 17 | Â |
Diabetes | 13 | Â |
Cardiovascular disease | 35 | Â |